✦ LIBER ✦

A Phase 1 Study of the Proteasome Inhibitor Bortezomib in Pediatric Patients with Refractory Leukemia: a Children's Oncology Group Study

✍ Scribed by Horton, T. M.; Pati, D.; Plon, S. E.; Thompson, P. A.; Bomgaars, L. R.; Adamson, P. C.; Ingle, A. M.; Wright, J.; Brockman, A. H.; Paton, M.; Blaney, S. M.

Book ID: 121758325
Publisher: American Association for Cancer Research
Year: 2007
Tongue: English
Weight: 308 KB
Volume: 13
Category: Article
ISSN: 1078-0432
DOI: 10.1158/1078-0432.CCR-06-2173

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 1 study of oxaliplatin and irinote

Phase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid tumors : A Children's Oncology Group Study

✍ Lisa M. McGregor; Sheri L. Spunt; Wayne L. Furman; Clinton F. Stewart; Paula Sch 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 533 KB

A phase II study of homoharringtonine fo

A phase II study of homoharringtonine for the treatment of children with refractory or recurrent acute myelogenous leukemia: A pediatric oncology group study

✍ Bell, Beverly A. ;Chang, Myron N. ;Weinstein, Howard J. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

## Abstract ## Background Homoharringtonine (HHT) is a plant alkaloid that is derived from a Chinese evergreen tree. Its mechanism of action is thought to be by inhibition of protein, DNA, and RNA synthesis by inhibition of chain initiation. The treatment of acute myelogenous leukemia (AML) in chi

Evaluation of AMSA in children with acut

Evaluation of AMSA in children with acute leukemia. A pediatric oncology group study

✍ Jeffrey Krischer; Vita J. Land; Curt I. Civin; Abdel H. Ragab; Donald H. Mahoney 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 366 KB 👁 2 views

A phase I trial of vorinostat and bortez

A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: A Children's Oncology Group phase I consortium study (ADVL0916)

✍ Jodi A. Muscal; Patrick A. Thompson; Terzah M. Horton; Ashish M. Ingle; Charlott 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

A Phase 2 study of bortezomib combined w

A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: A report from the Children's Oncology Group

✍ Horton, Terzah M.; Perentesis, John P.; Gamis, Alan S.; Alonzo, Todd A.; Gerbing 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

Rubidazone in the treatment of recurrent

Rubidazone in the treatment of recurrent acute leukemia in children. A pediatric oncology group study

✍ Abdelsalam H. Ragab; James M. Boyett; Lawrence Frankel; John Falletta 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 2 views